St Jude Medical's multi-electrode renal denervation technology was proven to be safe and effective and showed sustained reduction in office and ambulatory blood pressure measurements, at six months post treatment in patients with ...
Medtronic has begun its minimally invasive Symplicity renal denervation system's clinical trial in Japan to treat patients who are not responding to different types of anti-hypertensive medications and are at risk of stroke. The ...
Boston Scientific has entered into a definitive agreement to buy all the assets of Vessix Vascular for an upfront payment of $125m. Under the acquisition, Vessix Vascular will be integrated into Boston Scientific's peripheral ...
St Joseph Hospital has enrolled first patient for SYMPLICITY HTN-3 trial, conducted by Medtronic, designed to assess investigational Symplicity renal denervation system. Minimally invasive, catheter-based renal denervation procedure is ...
Tags: renal denervation system, catheter-based renal denervation